Patient selection for stroke thrombectomy

Six randomized controlled trials have established the substantial benefit of mechanical thrombectomy for acute ischemic stroke patients presenting with large vessel occlusive disease.1–6 Enrolling patients with large clinical deficit in the setting of small completed infarct and rapid, complete, or near complete recanalization, and treatment with the most recent generation of thrombectomy devices, contributed to this success. Efforts to generalize the results of these trials beyond select, experienced centers have focused attention on workflow and developing consensus on patient selection. Optimizing outcomes requires identifying patients most likely to improve and those most likely harmed with reperfusion. Imaging played a central role in selecting patients for these studies but the choice of imaging measures varied among studies. Some designs relied heavily on CT perfusion, multiphase CT angiography, or a combination of modalities, but all endeavored to identify the core (irreversibly infarcted brain), the penumbra (tissue at risk), or both.

[1]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[2]  A. Weill,et al.  Early CT changes in patients admitted for thrombectomy , 2016, Neurology.

[3]  H. Diener,et al.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. , 2015, The New England journal of medicine.

[4]  A. Demchuk,et al.  Thrombectomy within 8 hours after symptom onset in ischemic stroke. , 2015, The New England journal of medicine.

[5]  J. Mocco,et al.  State of acute endovascular therapy: report from the 12th thrombolysis, thrombectomy, and acute stroke therapy conference. , 2015, Stroke.

[6]  M. Krause,et al.  Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.

[7]  Eric E. Smith,et al.  Randomized assessment of rapid endovascular treatment of ischemic stroke. , 2015, The New England journal of medicine.

[8]  Hester F. Lingsma,et al.  A randomized trial of intraarterial treatment for acute ischemic stroke. , 2015, The New England journal of medicine.

[9]  Brian Silver,et al.  Importance of Early Ischemic Computed Tomography Changes Using ASPECTS in NINDS rtPA Stroke Study , 2005, Stroke.

[10]  A. Buchan,et al.  Selection of Acute Ischemic Stroke Patients for Intra-Arterial Thrombolysis With Pro-Urokinase by Using ASPECTS , 2003, Stroke.

[11]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.

[12]  C. Beaulieu,et al.  Comparison of diffusion-weighted MRI and CT in acute stroke , 2000, Neurology.

[13]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. , 2000, Lancet.

[14]  C. Beaulieu,et al.  Comparison of diffusion-weighted MRI and CT in acute stroke , 2000, Neurology.